Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain

Biological Psychiatry

Volumn 54, Issue 7, 2003, Pages 703-709

  Altar, C Anthony ^a,c   Whitehead, Richard E ^a   Chen, Ruoyan ^a   Wörtwein, Gitta ^b   Madsen, Torsten M ^b  

^a OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^b Rigshospitalet   (Denmark)

^c Psychiatric Genomics Inc   (United States)

Author keywords

BDNF; Depression; Fluoxetine; Frontal cortex; Hippocampus; Monoamine oxidase; Neurotrophin; Serotonin; SSRI

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DESIPRAMINE; FLUOXETINE; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; TRANYLCYPROMINE;

ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; FRONTAL CORTEX; HIPPOCAMPUS; KNOCKOUT MOUSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION; ANIMAL; ANIMAL DISEASE; BRAIN; C57BL MOUSE; COMPARATIVE STUDY; ELECTRIC SHOCK; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; GENOTYPE; HISTOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; SEIZURE; TIME;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; ELECTROSHOCK; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SEIZURES; TIME; TIME FACTORS;

EID: 0142040220     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00073-8     Document Type: Article

References (33)

1. Altar C.A. Neurotrophins and depression. Trends Pharmacol Sci. 20:1999;59-61.
2. Altar C.A., Boylan C.B., Fritsche M., Jackson C., Jones B.E., Wiegand S.W., et al. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions. J Neurochem. 63:1994;1021-1032.
3. Altar C.A., Cai N., Bliven T.T., Juhasz M., Connor J.R., Acheson A.L., et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature. 389:1997;856-860.
4. Altar C.A., DiStefano P.S. Neurotrophin trafficking by anterograde transport. Trends Neurosci. 21:1998;433-437.
5. Austin M.C., Whitehead R.E., Edgar C.L., Janosky J.E., Lewis D.A. Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide. Neurosci. 114:2002;807-815.
6. Benraiss A., Chmielnicki E., Lerner K., Roh D., Goldman S.A. Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J Neurosci. 21:2001;6718-6731.
7. Biegon A., Israeli M. Localization of the effects of electroconvulsive shock on beta- adrenoceptors in the rat brain. Eur J Pharmacol. 123:1986;329-334.
8. Chen B., Dowlatshahi D., MacQueen G.M., Wang H.J., Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry. 50:2001;260-265.
9. Croll S.D., Suri C., Compton D.L., Simmons M.V., Yancopoulos G.D., Lindsay R.M., et al. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience. 93:1999;1491-1506.
10. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry. 54:1997;597-606.
11. Eaton M.J., Staley J.K., Globus M.Y., Whittemore S.R. Developmental regulation of early serotonergic neuronal differentiation the role of brain-derived neurotrophic factor and membrane depolarization . Dev Biol. 170:1995;169-182.
12. Fochtmann L.J. Animal studies of electrocunvulsive therapy Foundations for future research . Psychopharmacol Bull. 30:1994;321-444.
13. Isackson P.J., Huntsman M.M., Murray K.D., Gall C.M. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures Temporal patterns of induction distinct from NGF . Neuron. 6:1991;937-948.
14. Lindsay R.M., Wiegand S.J., Altar C.A., DiStefano P.S. Neurotrophic factors From molecule to man . Trends Neurosci. 17:1994;182-190.
15. Madsen T.M., Treschow A., Bengzon J., Bolwig T.G., Lindvall O., Tingstrom A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry. 47:2000;1043-1049.
16. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 20:2000;9104-9110.
17. Mamounas L.A., Altar C.A., Blue M.A., Kaplan D.R., Tessarollo L., Lyons W.E. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adul rat brain. J Neurosci. 20:2000;771-782.
18. Mamounas L.A., Blue M.E., Siuciak J.A., Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci. 15:1995;7929-7939.
19. Martin-Iverson M.T., Todd K.G., Altar C.A. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors Interactions with amphetamine . J Neurosci. 14:1994;1262-1270.
20. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 15:1995;7539-7547.
21. Nibuya M., Nestler J.E., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci. 16:1996;2365-2372.
22. Pencea V., Bingaman K.D., Wiegand S.J., Luskin M.B. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci. 21:2001;6706-6717.
23. Radka S.F., Holst P.A., Fritsche M., Altar C.A. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res. 709:1996;122-301.
24. Rocamora N., Palacios J.M., Mengod G. Limbic seizures induce a differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor and neurotrophin- 3, in the rat hippocampus. Brain Res Mol Brain Res. 13:1992;27-33.
25. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci. 22:2002;3251-3261.
26. Siuciak J.A., Boylan C., Fritsche M., Altar C.A., Lindsay R.M. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res. 710:1996;11-20.
27. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav. 56:1997;131-137.
28. Skolnick P., Legutko B., Li X., Bymaster F.P. Current perspectives on the development of non-biogenic amine-based antidepressants. Pharmacol Res. 43:2001;411-423.
29. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 15:1995;1768-1777.
30. Smith M.A., Zhang L.X., Lyons W.E., Mamounas L.A. Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers. Neuroreport. 8:1997;1829-1834.
31. Stewart C.A., Reid I.C. Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology (Berl). 148:2000;217-223.
32. Volpe B.T., Wildmann J., Altar C.A. BDNF prevents the loss of nigral neurons induced by excitotoxic striatal lesions. Neurosci. 83:1998;741-748.
33. Zetterstrom T.S., Pei Q., Grahame-Smith D.G. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Brain Res Mol Brain Res. 57:1998;106-110.